A digoxin blood test measures how much digoxin is circulating in the blood after someone takes this heart medication. Digoxin can help some people with heart failure or atrial fibrillation, but the safe range is narrow, so a dose that is helpful for one person may be too much for another. The result is usually interpreted with symptoms, kidney function, potassium, magnesium, calcium, heart rhythm, age, body size, dose timing, and other medicines. A level that looks “normal” can still be unsafe if a person has nausea, confusion, a slow pulse, vision changes, or abnormal electrolytes. A level that looks high may also need context, especially if the blood was drawn too soon after a dose. The test is most useful when it is timed correctly and reviewed alongside the reason digoxin is being used.
- Digoxin is usually measured in ng/mL; 1 ng/mL is about 1.28 nmol/L.
- Many laboratories report a broad therapeutic range near 0.5–2.0 ng/mL, but heart failure targets are often lower, commonly about 0.5–0.9 ng/mL.
- Levels above 2.0 ng/mL raise concern for toxicity, but toxicity can happen below that level, especially in older adults or people with kidney disease.
- Blood is usually drawn at least 6 hours after a dose, often 8–12 hours after, or just before the next dose.
- Low potassium or magnesium can make digoxin more dangerous even when the digoxin level is not very high.
- Urgent care is important for suspected overdose, fainting, severe weakness, confusion, very slow pulse, chest symptoms, or new irregular heartbeat.
Table of Contents
- What the Digoxin Blood Test Measures
- Therapeutic Range, Toxic Level, and Units
- When the Test Is Ordered and How to Time It
- How to Interpret Digoxin Results
- Toxicity Symptoms and Urgent Results
- Medicines, Electrolytes, and Kidney Function
- Follow-Up Testing and Monitoring Plan
What the Digoxin Blood Test Measures
The digoxin blood test measures the concentration of digoxin in the bloodstream. Digoxin is a cardiac glycoside, a medicine that affects the sodium-potassium pump in heart cells. At the right dose, it can increase the force of heart muscle contraction and slow conduction through the atrioventricular node, which can help control heart rate in some people with atrial fibrillation.
Digoxin is used less often than it was in the past, but it still has a role in selected patients. It may be used in heart failure with reduced ejection fraction when symptoms persist despite other treatments, or in atrial fibrillation when rate control is difficult or when other medicines are not tolerated. The blood test does not decide by itself whether digoxin is the right medication. It shows whether the amount in the blood fits the expected range for the person’s condition and timing.
This test is part of therapeutic drug monitoring, which means checking a drug level because the margin between helpful and harmful can be small. Digoxin is a classic example of a medication that benefits from careful monitoring. A therapeutic drug monitoring panel may include other narrow-range medicines, but digoxin needs its own interpretation because heart rhythm, kidney clearance, and electrolytes strongly shape the risk.
A digoxin level is usually reported from serum or plasma, not whole blood. The result is most often given in nanograms per milliliter, written as ng/mL. Some laboratories also report nanomoles per liter, written as nmol/L. The conversion is approximate: 1 ng/mL of digoxin is about 1.28 nmol/L.
The blood level mainly reflects the amount of drug in the blood after distribution into tissues. This is important because digoxin moves from blood into muscle and other tissues after a dose. If blood is drawn too soon, the result may look falsely high compared with the stable level that matters clinically.
Therapeutic Range, Toxic Level, and Units
A common laboratory therapeutic range for digoxin is about 0.5–2.0 ng/mL. This broad range is easy to remember, but it can be misleading if used without context. Many people with heart failure are managed with a lower target, often about 0.5–0.9 ng/mL, because higher levels may add toxicity risk without clear added benefit. For atrial fibrillation, the ideal level may depend more on heart rate response, symptoms, and whether other rate-control medicines are being used.
| Digoxin result | Approximate nmol/L | Common meaning | Important caution |
|---|---|---|---|
| Less than 0.5 ng/mL | Less than 0.6 nmol/L | May be below the expected treatment range | May still be acceptable if symptoms and heart rate are controlled |
| 0.5–0.9 ng/mL | 0.6–1.2 nmol/L | Often a preferred range for many heart failure patients | Not automatically safe if toxicity symptoms or electrolyte problems are present |
| 1.0–2.0 ng/mL | 1.3–2.6 nmol/L | May fall within some laboratory therapeutic ranges | Higher levels may be less desirable in heart failure and may increase risk in vulnerable patients |
| More than 2.0 ng/mL | More than 2.6 nmol/L | Raises concern for possible toxicity | Interpret timing, symptoms, kidney function, potassium, and ECG findings urgently |
A “toxic level” is often described as greater than 2.0 ng/mL, but the number is not a hard border between safe and unsafe. Digoxin toxicity can occur at lower levels in older adults, people with reduced kidney function, people with low potassium or low magnesium, and people taking interacting medications. Some patients feel unwell with levels that would not alarm the laboratory. Others may have a level above the reference range but no symptoms if the test was drawn too soon after a dose.
For heart failure, a lower serum concentration is usually preferred. Digoxin can reduce hospitalizations in selected heart failure patients, but it is not one of the main modern medications proven to improve survival the way several newer heart failure therapies can. That is one reason clinicians often aim for the lowest useful level rather than the top of the laboratory range.
For atrial fibrillation, the blood level must be paired with the pulse and ECG. A person may have a “therapeutic” digoxin level but still have a heart rate that is too fast. Another person may have a level in range but a pulse that is too slow, especially if they also take a beta blocker, diltiazem, verapamil, or amiodarone.
When the Test Is Ordered and How to Time It
A digoxin test is ordered when a clinician needs to know whether the blood level fits the dose, the timing, and the patient’s condition. It may be checked after starting digoxin, after a dose change, after kidney function changes, after adding or stopping an interacting medication, or when symptoms suggest toxicity.
Correct timing is one of the biggest factors in getting a useful result. Digoxin distributes slowly from the bloodstream into tissues. A blood sample drawn soon after a dose can look high because the medicine has not finished moving into tissues. For routine monitoring, blood is commonly drawn at least 6 hours after the last dose. Many clinicians prefer 8–12 hours after the dose or a trough level just before the next dose.
A steady-state level is usually checked after the body has had enough time to settle into the dose. In many adults with stable kidney function, this may take about 5–7 days. In people with reduced kidney function, it can take longer because digoxin is cleared mainly through the kidneys. Checking too early after a new dose may lead to unnecessary dose changes.
Common reasons to order the test include:
- New nausea, vomiting, appetite loss, abdominal pain, confusion, dizziness, or vision changes in a person taking digoxin
- New slow pulse, fainting, palpitations, or abnormal ECG findings
- Worsening kidney function, dehydration, vomiting, diarrhea, or sudden illness
- Dose changes or unclear adherence
- Starting or stopping interacting medicines
- Checking whether a low dose is enough for heart rate control or heart failure symptoms
The test usually requires a standard blood draw from a vein. Fasting is not usually required. The most important preparation is knowing exactly when the last digoxin dose was taken. A result without dose timing is harder to interpret.
For someone who takes digoxin in the morning, a clinician may ask for a blood draw later that day or the next morning before the dose. For someone on an every-other-day schedule, the timing should be written clearly on the lab order or discussed with the healthcare team.
How to Interpret Digoxin Results
Digoxin results are interpreted in layers. The number matters, but the surrounding clinical picture matters more. A safe interpretation asks: Why is the person taking digoxin? When was the blood drawn? What dose are they taking? Are they having symptoms? What are their potassium, magnesium, calcium, creatinine, and ECG findings?
A low digoxin level may mean the dose is too low, doses were missed, absorption is poor, or the blood was drawn after a long interval. It can also be acceptable if the person is stable and the medication is being used cautiously. The goal is not to push every person into the upper half of the laboratory range.
A level in the preferred range may support continuing the current dose, especially if the heart rate, symptoms, kidney function, and electrolytes are stable. For heart failure, a level around 0.5–0.9 ng/mL is often considered enough. For atrial fibrillation, the result should be judged against heart rate control at rest and with activity.
A high level may suggest excess dosing, reduced kidney clearance, dehydration, drug interaction, incorrect timing, or accidental double dosing. If symptoms are present, a high level becomes more concerning. If the person has no symptoms and the sample was drawn too soon after a dose, the clinician may repeat the test at the correct time before changing the dose.
| Pattern | Likely concern | Typical next step |
|---|---|---|
| High digoxin with nausea, confusion, or slow pulse | Possible digoxin toxicity | Prompt clinical review, ECG, electrolytes, kidney tests, and medication hold or treatment decision |
| Normal digoxin with low potassium | Toxicity risk can still be increased | Correct potassium and review diuretics, kidney function, and symptoms |
| High digoxin after a recent dose | Possible mistimed sample | Repeat level at least 6–8 hours after dosing if clinically safe |
| Low digoxin with fast atrial fibrillation | Possible underexposure or need for different rate-control plan | Review adherence, dose, timing, kidney function, and other rate-control options |
| Rising digoxin with rising creatinine | Reduced kidney clearance | Adjust dose or interval and monitor kidney function closely |
A helpful way to think about digoxin is that the result is a risk-and-response marker, not a simple pass-or-fail test. The same number can have different meaning in a young adult with stable kidneys and in an older adult with dehydration, low potassium, and new confusion.
The connection between digoxin and potassium is especially important. A separate discussion of digoxin level and potassium can help explain why a digoxin result that looks only mildly high may still be risky when potassium is abnormal.
Toxicity Symptoms and Urgent Results
Digoxin toxicity can develop after a large overdose or slowly during regular treatment. Chronic toxicity is common in older adults because kidney function, body water, medication lists, and electrolyte balance can change gradually. A person may be taking the same dose for years and become toxic after dehydration, kidney decline, a new medicine, or a change in diuretic dose.
Symptoms can be vague at first. Loss of appetite, nausea, vomiting, diarrhea, fatigue, weakness, dizziness, confusion, and unusual sleepiness may appear before obvious heart symptoms. Some people notice blurred vision, yellow-green color changes, halos, or trouble focusing. These symptoms are not specific to digoxin, but they deserve attention when they appear in someone taking it.
Heart rhythm effects are the most dangerous part of digoxin toxicity. Digoxin can cause slow heart rate, atrioventricular block, premature beats, ventricular tachycardia, and other abnormal rhythms. An ECG is often more important than the blood level when symptoms are serious.
Urgent medical evaluation is needed when a person taking digoxin has:
- Fainting, near-fainting, severe dizziness, or new confusion
- Very slow pulse, new irregular heartbeat, or palpitations with weakness
- Chest pain, shortness of breath, or severe fatigue
- Repeated vomiting or inability to keep fluids down
- Suspected extra doses, accidental overdose, or child exposure
- Digoxin level above the laboratory’s critical threshold
- High potassium in the setting of suspected acute overdose
- Severe kidney function worsening or severe electrolyte abnormality
A key nuance is that potassium can point in different directions depending on the situation. Low potassium makes the heart more sensitive to digoxin and can trigger toxicity even when the digoxin level is not very high. High potassium during acute digoxin poisoning can be a warning sign of severe poisoning because digoxin blocks the sodium-potassium pump.
Severe toxicity may be treated with digoxin-specific antibody fragments, often called digoxin immune Fab. This treatment binds digoxin and is used for life-threatening poisoning, dangerous arrhythmias, cardiac arrest, severe hyperkalemia from acute poisoning, or other high-risk situations. After this treatment, total digoxin levels may become difficult to interpret because standard tests can detect bound digoxin. Clinicians then follow symptoms, ECG, potassium, kidney function, and specialized free digoxin testing if needed.
Medicines, Electrolytes, and Kidney Function
Digoxin is strongly affected by kidney function. The kidneys clear much of the drug from the body, so a dose that was once appropriate can become too high when creatinine rises or eGFR falls. Older adults are especially vulnerable because muscle mass can be low, and a “not too bad” creatinine may still reflect reduced kidney clearance.
Kidney monitoring usually includes creatinine and estimated glomerular filtration rate, or eGFR. A broader kidney function blood test panel can also include blood urea nitrogen and electrolytes, which help explain whether dehydration, kidney disease, or medication effects are increasing digoxin risk.
Electrolytes are just as important as the digoxin number. Low potassium, low magnesium, and high calcium can increase the risk of rhythm problems. Loop diuretics such as furosemide and torsemide, and thiazide-type diuretics such as hydrochlorothiazide, can lower potassium or magnesium. Vomiting and diarrhea can do the same. Kidney disease and potassium-sparing medicines can push potassium too high.
A pattern involving potassium, creatinine, and heart rhythm risk often needs careful review. The relationship between potassium and creatinine is especially relevant when a person is taking digoxin, diuretics, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, or potassium supplements.
Many medicines can raise digoxin levels by reducing clearance or affecting transport proteins such as P-glycoprotein. Important examples include amiodarone, quinidine, verapamil, diltiazem, dronedarone, certain macrolide antibiotics, some azole antifungals, cyclosporine, and some antiarrhythmic drugs. Spironolactone may affect digoxin levels and may also interfere with some assays depending on the test method.
Other substances can lower digoxin levels or reduce its effect. Some antacids, bile acid binders, and high-fiber supplements can reduce absorption if taken too close to digoxin. St. John’s wort may lower digoxin exposure. Changes in thyroid status can also affect response: hyperthyroidism may reduce digoxin effect, while hypothyroidism can increase sensitivity.
Because interactions are common, a digoxin result should be reviewed whenever a medication list changes. The list should include prescriptions, over-the-counter medicines, supplements, herbal products, and recent antibiotics.
Follow-Up Testing and Monitoring Plan
Follow-up depends on why the test was done. A stable patient with a low-dose regimen, normal kidney function, normal electrolytes, and no symptoms may only need periodic monitoring. A person with changing kidney function, new symptoms, recent dose changes, or interacting medicines needs closer follow-up.
Common follow-up tests include a repeat digoxin level, creatinine, eGFR, potassium, magnesium, calcium, and an ECG. A basic metabolic panel or comprehensive metabolic panel may be used to check kidney function and electrolytes, depending on the clinical setting. Magnesium may need to be ordered separately if it is not included.
A practical monitoring plan often includes these steps:
- Confirm the dose and schedule.
Digoxin may be taken daily, every other day, or on another individualized schedule. Confusion between micrograms and milligrams can be dangerous. Most outpatient digoxin tablets are measured in micrograms, such as 125 mcg or 250 mcg. - Record the timing of the last dose.
The lab result should be interpreted with the exact time of the last dose and blood draw. Without this, a high level may be hard to judge. - Check kidney function and electrolytes at the same time.
A digoxin level without potassium and creatinine gives an incomplete safety picture. Magnesium and calcium can also matter. - Compare the level with the treatment reason.
A heart failure target may be lower than a broad laboratory range. Atrial fibrillation management also depends on heart rate and symptoms. - Review new medications and recent illnesses.
Antibiotics, antiarrhythmics, dehydration, diarrhea, vomiting, and kidney injury can all change risk quickly. - Decide whether to continue, hold, reduce, or repeat.
The safest next step depends on symptoms, ECG findings, level timing, and the seriousness of the result. Patients should not change digoxin dosing without medical advice unless they have been given a specific plan.
Patients can make the test more useful by bringing a current medication list and writing down the exact time they took digoxin. They should also tell the clinician about missed doses, extra doses, nausea, appetite changes, dizziness, visual symptoms, diarrhea, dehydration, or new over-the-counter products.
Digoxin monitoring works best as a pattern, not a single number. The most reassuring pattern is stable symptoms, stable pulse, stable kidney function, normal electrolytes, and a properly timed level in the intended range. The most concerning pattern is new symptoms, abnormal potassium, rising creatinine, abnormal ECG, or a level above the expected range.
References
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines 2022 (Guideline)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2021 (Guideline)
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines 2023 (Guideline)
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 2024 (Guideline)
- Management of digoxin toxicity 2016 (Review)
- Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial 2006 (Review)
Disclaimer
Digoxin dosing and toxicity decisions should be made by a qualified healthcare professional who can review symptoms, ECG findings, kidney function, electrolytes, medication interactions, and the timing of the blood draw. Seek urgent medical care for suspected overdose, fainting, severe weakness, confusion, severe vomiting, a very slow pulse, or a new irregular heartbeat while taking digoxin.
